Hormonal resuscitation yields more transplanted hearts, with improved early function.

Area of Science:

• Cardiology
• Transplantation Medicine
• Endocrinology

Background:

• Brain death often causes cardiovascular instability, impairing organ quality for transplantation.
• Hormonal resuscitation protocols have shown promise in stabilizing brain-dead donors.
• Increased organ transplantation numbers per donor have been linked to hormonal therapy.

Purpose of the Study:

• To evaluate the quality of heart grafts from brain-dead donors treated with hormonal resuscitation.
• To compare short-term outcomes of heart transplants using grafts from donors receiving three-drug hormonal resuscitation (3HR) versus those not receiving the full regimen (non-3HR).

Main Methods:

• Retrospective analysis of 4,543 heart transplant recipients from the UNOS/OPTN database (Nov 1999 - Dec 2001).
• Hormonal resuscitation involved methylprednisolone, vasopressin, and either triiodothyronine or l-thyroxine.
• Univariate and multivariate analyses assessed 30-day mortality and early graft dysfunction as endpoints.

Main Results:

• Hearts from 3HR donors had a 96.2% 1-month survival rate versus 92.1% for non-3HR (P<0.01).
• Early graft dysfunction occurred in 5.6% of 3HR hearts vs. 11.6% of non-3HR hearts (P<0.01).
• Multivariate analysis showed 46% reduced odds of 30-day death and 48% reduced odds of early graft dysfunction with 3HR.

Conclusions:

• Three-drug hormonal resuscitation (3HR) for brain-dead donors improves short-term heart graft function.
• This treatment strategy increases the number of viable hearts available for transplantation.
• Further investigation into hormonal resuscitation protocols is warranted for optimizing organ donor management.